Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Company Timeline (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,467.00    -11.00 (-0.74%)
Bid:
1,489.00
Ask:
1,490.00
Spread: 1.00 (0.067%)
Market Cap: £3.14b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Latest Timeline Updates for Hikma Pharmaceuticals

HIK

RNS
18 May 2026 10:55
Hikma Pharmaceuticals

Date:
18-May-26

Time:
10:55 am

Source:
RNS

HIK

RNS
15 May 2026 09:45
Hikma Pharmaceuticals

Date:
15-May-26

Time:
9:45 am

Source:
RNS

HIK

RNS
11 May 2026 13:10
Hikma Pharmaceuticals

Date:
11-May-26

Time:
1:10 pm

Source:
RNS

HIK

RNS
6 May 2026 15:08
Hikma Pharmaceuticals

Date:
06-May-26

Time:
3:08 pm

Source:
RNS

HIK

RNS
5 May 2026 09:55
Hikma Pharmaceuticals

Date:
05-May-26

Time:
9:55 am

Source:
RNS

HIK

News
5 May 2026 09:35
Hikma Pharmaceuticals

LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities

(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday:

HIK

Broker Rating
5 May 2026 09:20
Hikma Pharmaceuticals

Date:
05-May-26

Broker:
Jefferies

Recommendation:
Buy

Old Target:
1,850.00

New Target:
1,870.00

Rating Type:
Reiteration

HIK

RNS
1 May 2026 10:36
Hikma Pharmaceuticals

Date:
01-May-26

Time:
10:36 am

Source:
RNS

HIK

News
29 Apr 2026 22:29
Hikma Pharmaceuticals

UPDATE 1-US Supreme Court to hear 'skinny label' patent fight involving Amarin

* Amarin Pharma sued British generic drug ​maker Hikma

HIK

News
28 Apr 2026 17:00
Hikma Pharmaceuticals

Pfizer secures deals to keep heart drug free of generic rivals until 2031

April 28 (Reuters) - Pfizer said on Tuesday ​it has ‌settled patent disputes with three generic drugmakers over its blockbuster ⁠heart drug Vyndamax, effectively extending its patent ⁠protection until...

HIK

Directors Deal
28 Apr 2026 15:50
Hikma Pharmaceuticals

Date:
28-Apr-26

Action:
Buy

Notifier:
Victoria Hull
(Chairman)

Price:
1,376.00

Amount:
-

Holding:
3,214

HIK

RNS
28 Apr 2026 13:29
Hikma Pharmaceuticals

Date:
28-Apr-26

Time:
1:29 pm

Source:
RNS

HIK

Broker Rating
28 Apr 2026 09:40
Hikma Pharmaceuticals

Date:
28-Apr-26

Broker:
Berenberg Bank

Recommendation:
Buy

Old Target:
1,800.00

New Target:
1,800.00

Rating Type:
Reiteration

HIK

RNS
27 Apr 2026 11:55
Hikma Pharmaceuticals

Date:
27-Apr-26

Time:
11:55 am

Source:
RNS